IBDEI02G ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2759,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,2759,1,8,0)
 ;;=8^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,2759,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,2760,0)
 ;;=238.72^^26^196^7
 ;;^UTILITY(U,$J,358.3,2760,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2760,1,1,0)
 ;;=1^238.72
 ;;^UTILITY(U,$J,358.3,2760,1,8,0)
 ;;=8^Low Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,2760,2)
 ;;=^334028
 ;;^UTILITY(U,$J,358.3,2761,0)
 ;;=238.73^^26^196^5
 ;;^UTILITY(U,$J,358.3,2761,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2761,1,1,0)
 ;;=1^238.73
 ;;^UTILITY(U,$J,358.3,2761,1,8,0)
 ;;=8^High Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,2761,2)
 ;;=^334029
 ;;^UTILITY(U,$J,358.3,2762,0)
 ;;=238.74^^26^196^9
 ;;^UTILITY(U,$J,358.3,2762,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2762,1,1,0)
 ;;=1^238.74
 ;;^UTILITY(U,$J,358.3,2762,1,8,0)
 ;;=8^Myelody Synd w/ 5q Deletion
 ;;^UTILITY(U,$J,358.3,2762,2)
 ;;=^334030
 ;;^UTILITY(U,$J,358.3,2763,0)
 ;;=238.75^^26^196^10
 ;;^UTILITY(U,$J,358.3,2763,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2763,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,2763,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,2763,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,2764,0)
 ;;=238.76^^26^196^11
 ;;^UTILITY(U,$J,358.3,2764,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2764,1,1,0)
 ;;=1^238.76
 ;;^UTILITY(U,$J,358.3,2764,1,8,0)
 ;;=8^Myelofibrosis w/Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,2764,2)
 ;;=^334032
 ;;^UTILITY(U,$J,358.3,2765,0)
 ;;=238.77^^26^196^16
 ;;^UTILITY(U,$J,358.3,2765,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2765,1,1,0)
 ;;=1^238.77
 ;;^UTILITY(U,$J,358.3,2765,1,8,0)
 ;;=8^Post Transp Lymphoprolif d/o PTLD
 ;;^UTILITY(U,$J,358.3,2765,2)
 ;;=^336526
 ;;^UTILITY(U,$J,358.3,2766,0)
 ;;=238.79^^26^196^12
 ;;^UTILITY(U,$J,358.3,2766,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2766,1,1,0)
 ;;=1^238.79
 ;;^UTILITY(U,$J,358.3,2766,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue
 ;;^UTILITY(U,$J,358.3,2766,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,2767,0)
 ;;=238.8^^26^196^13
 ;;^UTILITY(U,$J,358.3,2767,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2767,1,1,0)
 ;;=1^238.8
 ;;^UTILITY(U,$J,358.3,2767,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue NEC
 ;;^UTILITY(U,$J,358.3,2767,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,2768,0)
 ;;=238.9^^26^196^8
 ;;^UTILITY(U,$J,358.3,2768,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2768,1,1,0)
 ;;=1^238.9
 ;;^UTILITY(U,$J,358.3,2768,1,8,0)
 ;;=8^Lymph/Hematopoietic Tissue NOS
 ;;^UTILITY(U,$J,358.3,2768,2)
 ;;=^267780
 ;;^UTILITY(U,$J,358.3,2769,0)
 ;;=239.0^^26^197^5
 ;;^UTILITY(U,$J,358.3,2769,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2769,1,1,0)
 ;;=1^239.0
 ;;^UTILITY(U,$J,358.3,2769,1,8,0)
 ;;=8^Digestive Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2769,2)
 ;;=^267781
 ;;^UTILITY(U,$J,358.3,2770,0)
 ;;=239.1^^26^197^11
 ;;^UTILITY(U,$J,358.3,2770,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2770,1,1,0)
 ;;=1^239.1
 ;;^UTILITY(U,$J,358.3,2770,1,8,0)
 ;;=8^Respiratory Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2770,2)
 ;;=^267782
 ;;^UTILITY(U,$J,358.3,2771,0)
 ;;=239.2^^26^197^2
 ;;^UTILITY(U,$J,358.3,2771,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2771,1,1,0)
 ;;=1^239.2
 ;;^UTILITY(U,$J,358.3,2771,1,8,0)
 ;;=8^Bone,Soft Tissue,Skin Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2771,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,2772,0)
 ;;=239.3^^26^197^4
 ;;^UTILITY(U,$J,358.3,2772,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2772,1,1,0)
 ;;=1^239.3
 ;;^UTILITY(U,$J,358.3,2772,1,8,0)
 ;;=8^Breast Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2772,2)
 ;;=^81977
 ;;^UTILITY(U,$J,358.3,2773,0)
 ;;=239.4^^26^197^1
 ;;^UTILITY(U,$J,358.3,2773,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2773,1,1,0)
 ;;=1^239.4
 ;;^UTILITY(U,$J,358.3,2773,1,8,0)
 ;;=8^Bladder Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2773,2)
 ;;=^81975
 ;;^UTILITY(U,$J,358.3,2774,0)
 ;;=239.5^^26^197^9
 ;;^UTILITY(U,$J,358.3,2774,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2774,1,1,0)
 ;;=1^239.5
 ;;^UTILITY(U,$J,358.3,2774,1,8,0)
 ;;=8^Oth Genitourinary Org Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2774,2)
 ;;=^267784
 ;;^UTILITY(U,$J,358.3,2775,0)
 ;;=239.6^^26^197^3
 ;;^UTILITY(U,$J,358.3,2775,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2775,1,1,0)
 ;;=1^239.6
 ;;^UTILITY(U,$J,358.3,2775,1,8,0)
 ;;=8^Brain Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2775,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,2776,0)
 ;;=239.7^^26^197^6
 ;;^UTILITY(U,$J,358.3,2776,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2776,1,1,0)
 ;;=1^239.7
 ;;^UTILITY(U,$J,358.3,2776,1,8,0)
 ;;=8^Endocrine/Nerv Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2776,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,2777,0)
 ;;=239.81^^26^197^12
 ;;^UTILITY(U,$J,358.3,2777,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2777,1,1,0)
 ;;=1^239.81
 ;;^UTILITY(U,$J,358.3,2777,1,8,0)
 ;;=8^Retina/Choroid Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,2777,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,2778,0)
 ;;=239.89^^26^197^7
 ;;^UTILITY(U,$J,358.3,2778,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2778,1,1,0)
 ;;=1^239.89
 ;;^UTILITY(U,$J,358.3,2778,1,8,0)
 ;;=8^Neoplasm,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,2778,2)
 ;;=^338225
 ;;^UTILITY(U,$J,358.3,2779,0)
 ;;=239.9^^26^197^8
 ;;^UTILITY(U,$J,358.3,2779,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2779,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,2779,1,8,0)
 ;;=8^Neoplasm,Unspec Site 
 ;;^UTILITY(U,$J,358.3,2779,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,2780,0)
 ;;=288.9^^26^197^15
 ;;^UTILITY(U,$J,358.3,2780,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2780,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,2780,1,8,0)
 ;;=8^Unspec Dis of WBC
 ;;^UTILITY(U,$J,358.3,2780,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,2781,0)
 ;;=289.0^^26^197^13
 ;;^UTILITY(U,$J,358.3,2781,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2781,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,2781,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,2781,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,2782,0)
 ;;=289.81^^26^197^10
 ;;^UTILITY(U,$J,358.3,2782,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2782,1,1,0)
 ;;=1^289.81
 ;;^UTILITY(U,$J,358.3,2782,1,8,0)
 ;;=8^Primary Hypercoagulable State
 ;;^UTILITY(U,$J,358.3,2782,2)
 ;;=^329886
 ;;^UTILITY(U,$J,358.3,2783,0)
 ;;=289.9^^26^197^14
 ;;^UTILITY(U,$J,358.3,2783,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,2783,1,1,0)
 ;;=1^289.9
 ;;^UTILITY(U,$J,358.3,2783,1,8,0)
 ;;=8^Unspec Blood Disease
 ;;^UTILITY(U,$J,358.3,2783,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,2784,0)
 ;;=99201^^27^198^1
 ;;^UTILITY(U,$J,358.3,2784,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2784,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,2784,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,2785,0)
 ;;=99202^^27^198^2
 ;;^UTILITY(U,$J,358.3,2785,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2785,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,2785,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,2786,0)
 ;;=99203^^27^198^3
 ;;^UTILITY(U,$J,358.3,2786,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2786,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,2786,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,2787,0)
 ;;=99204^^27^198^4
 ;;^UTILITY(U,$J,358.3,2787,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2787,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,2787,1,2,0)
 ;;=2^99204
 ;;^UTILITY(U,$J,358.3,2788,0)
 ;;=99212^^27^199^2
 ;;^UTILITY(U,$J,358.3,2788,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2788,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,2788,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,2789,0)
 ;;=99213^^27^199^3
 ;;^UTILITY(U,$J,358.3,2789,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2789,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,2789,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,2790,0)
 ;;=99214^^27^199^4
 ;;^UTILITY(U,$J,358.3,2790,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2790,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,2790,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,2791,0)
 ;;=99241^^27^200^1
 ;;^UTILITY(U,$J,358.3,2791,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2791,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,2791,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,2792,0)
 ;;=99242^^27^200^2
 ;;^UTILITY(U,$J,358.3,2792,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2792,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,2792,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,2793,0)
 ;;=99243^^27^200^3
 ;;^UTILITY(U,$J,358.3,2793,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2793,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,2793,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,2794,0)
 ;;=99244^^27^200^4
 ;;^UTILITY(U,$J,358.3,2794,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2794,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,2794,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,2795,0)
 ;;=99245^^27^200^5
 ;;^UTILITY(U,$J,358.3,2795,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2795,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,2795,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,2796,0)
 ;;=726.0^^28^201^3
 ;;^UTILITY(U,$J,358.3,2796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2796,1,3,0)
 ;;=3^Adhesive Capsulit Shlder
 ;;^UTILITY(U,$J,358.3,2796,1,4,0)
 ;;=4^726.0
 ;;^UTILITY(U,$J,358.3,2796,2)
 ;;=^272520
 ;;^UTILITY(U,$J,358.3,2797,0)
 ;;=716.98^^28^201^5
 ;;^UTILITY(U,$J,358.3,2797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2797,1,3,0)
 ;;=3^Arthropathy Nos-Oth Site
 ;;^UTILITY(U,$J,358.3,2797,1,4,0)
 ;;=4^716.98
 ;;^UTILITY(U,$J,358.3,2797,2)
 ;;=^272255
 ;;^UTILITY(U,$J,358.3,2798,0)
 ;;=714.0^^28^201^109
 ;;^UTILITY(U,$J,358.3,2798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2798,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,2798,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,2798,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,2799,0)
 ;;=726.71^^28^201^1
 ;;^UTILITY(U,$J,358.3,2799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2799,1,3,0)
 ;;=3^Achilles Tendinitis
